MOCAc-Lys-Pro-Leu-Gly-Leu-A2pr(DNP)-Ala-Arg-NH2

MOCAc-Lys-Pro-Leu-Gly-Leu-A2pr(DNP)-Ala-Arg-NH2

1 mg
€129,00

Sie können eine Angebotsanfrage erstellen, nachdem Sie das Produkt in den Warenkorb gelegt haben.

Zu Produktinformationen springen
MOCAc-Lys-Pro-Leu-Gly-Leu-A2pr(DNP)-Ala-Arg-NH2
  • MOCAc-Lys-Pro-Leu-Gly-Leu-A2pr(DNP)-Ala-Arg-NH2
  • MOCAc-Lys-Pro-Leu-Gly-Leu-A2pr(DNP)-Ala-Arg-NH2

MOCAc-Lys-Pro-Leu-Gly-Leu-A2pr(DNP)-Ala-Arg-NH2

Produkt-ID: 3226

(7-Methoxycoumarin-4-yl)acetyl- L-lysyl- L-prolyl- L-leucyl- glycyl- L-leucyl- [Nβ-(2,4- dinitrophenyl)- L-2,3-diaminopropionyl]- L-alanyl- L-arginine amide

€129,00
exkl. 19% MwSt.
Beschreibung

M.W. 1221.30

C55H80N16O16

(7-Methoxycoumarin-4-yl)acetyl- L-lysyl- L-prolyl- L-leucyl- glycyl- L-leucyl- [Nβ-(2,4- dinitrophenyl)- L-2,3-diaminopropionyl]- L-alanyl- L-arginine amide

Fluorescence-Quenching Substrate for Matrix Metalloproteinases and ADAM-17 / Tumor Necrosis Factor Converting Enzyme (TACE)MOCAc-Lys-Pro-Leu-Gly-Leu-A2pr(DNP)-Ala-Arg-NH2 is a commonly used Fluorescence-Quenching Substrate from MCA / DNP type.

Synthetic Product (Trifluoracetate Form)

A trace of impurity might be detectable by TLC when 100 µg is applied to the plate. The amount of contamination detectable by HPLC is less than 2 %.

Referenzen:

1. U. Neumann, H. Kubota, K. Frei, V. Ganu and D. Leppert, Anal. Biochem., 328, 166 (2004) 2. A. Trifilieff, C. Walker, T. Keller, G. Kottirsch and U. Neumann, Br. J. Pharmacol., 135, 1655 (2002) 3. M.C. Riitano, H. Pfister, P. Engelhardt, U. Neumann, M. Reist, A. Zurbriggen, M. Stoffel, J. Peel, T. Jungi, P. Schawalder and D.E. Spreng, Am. J. Vet. Res., 63, 1423 (2002)

You may also like